Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies

Genetics in Medicine

Volumn 19, Issue 3, 2017, Pages 306-313

  Brison, Nathalie ^a   Van Den Bogaert, Kris ^a   Dehaspe, Luc ^a   Van Den Oever, Jessica M E ^a   Janssens, Katrien ^b   Blaumeiser, Bettina ^b   Peeters, Hilde ^a   Van Esch, Hilde ^a   Van Buggenhout, Griet ^a   Vogels, Annick ^a   De Ravel, Thomy ^a   Legius, Eric ^a   Devriendt, Koen ^a   Vermeesch, Joris R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Copy Number Variation; Maternal Incidental Findings; Noninvasive Prenatal Testing

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHM PROTEIN; DNA; POU3F4 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR RUNX1; UBE2A PROTEIN; UNCLASSIFIED DRUG; ZNF11 PROTEIN; CELL FREE NUCLEIC ACID;

ADULT; ANEUPLOIDY; ANXIETY DISORDER; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 3; CHROMOSOME DELETION 13; CHROMOSOME DELETION X; CHROMOSOME DUPLICATION; CHROMOSOME MOSAICISM; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA EXTRACTION; ENZYME RELEASE; FEMALE; FETUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC COUNSELING; HAPLOINSUFFICIENCY; HOMOLOGOUS RECOMBINATION; HUMAN; INCIDENCE; INCIDENTAL FINDING; INTELLECTUAL IMPAIRMENT; KARYOTYPING; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MONOSOMY; MONOSOMY 21; NON INVASIVE PROCEDURE; PERCEPTION DEAFNESS; PREGNANT WOMAN; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; SEGMENTAL DUPLICATION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; YOUNG ADULT; BLOOD; CASE REPORT; CHROMOSOME ABERRATION; DNA SEQUENCE; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; PREGNANCY; PROCEDURES;

ADULT; ANEUPLOIDY; CELL-FREE NUCLEIC ACIDS; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA; DNA COPY NUMBER VARIATIONS; FEMALE; FETUS; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENTAL FINDINGS; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 85014853076     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2016.113     Document Type: Article

References (40)

1. Liao GJ, Lun FM, Zheng YW, et al. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 2011;57:92-101.
2. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-137.e8.
3. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
4. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 2011;13:913-920.
5. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-205.11.
6. Zhang H, Gao Y, Jiang F, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015;45:530-538.
7. Boon EM, Faas BH. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies. Prenat Diagn 2013;33:563-568.
8. McCullough RM, Almasri EA, Guan X, et al. Non-invasive prenatal chromosomal aneuploidy testing-clinical experience: 100,000 clinical samples. PLoS One 2014;9:e109173.
9. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92:167-176.
10. Lau TK, Jiang FM, Stevenson RJ, et al. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 2013;33:602-608.
11. Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60:251-259.
12. Wang S, Huang S, Ma L, et al. Maternal X chromosome copy number variations are associated with discordant fetal sex chromosome aneuploidies detected by noninvasive prenatal testing. Clin Chim Acta 2015;444:113-116.
13. Bayindir B, Dehaspe L, Brison N, et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet 2015;23:1286-1293.
14. Flowers N, Kelley J, Sigurjonsson S, Bruno DL, Pertile MD. Maternal mosaicism for a large segmental duplication of 18q as a secondary finding following non-invasive prenatal testing and implications for test accuracy. Prenat Diagn 2015;35:986-989.
15. Wapner RJ, Babiarz JE, Levy B, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015;212:332.e1-332.e9.
16. Brady P, Brison N, Van Den Bogaert K, et al. Clinical implementation of NIPT-Technical and biological challenges. Clin Genet 2016;89:523-530.
17. Helgeson J, Wardrop J, Boomer T, et al. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015;35:999-1004.
18. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-611.
19. Amant F, Verheecke M, Wlodarska I, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol 2015;1:814-819.
20. Bianchi DW, Chudova D, Sehnert AJ, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015;314: 162-169.
21. Vandenberghe P, Wlodarska I, Tousseyn T, et al. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkins lymphoma by sequencing of circulating cell-free DNA: A technical proof-of-principle study. Lancet Haematol 2015;2:e55-e65.
22. Shen J, Zhang NR. Change-point model on nonhomogeneous poisson processes with application in copy number profiling by next-generation DNA sequencing. Ann Appl Stat 2012;6:476-496.
23. Vandeweyer G, Reyniers E, Wuyts W, Rooms L, Kooy RF. CNV-WebStore: online CNV analysis, storage and interpretation. BMC Bioinformatics 2011;12:4.
24. Sahoo T, Theisen A, Rosenfeld JA, et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet Med 2011;13:868-880.
25. Grayton HM, Fernandes C, Rujescu D, Collier DA. Copy number variations in neurodevelopmental disorders. Prog Neurobiol 2012;99:81-91.
26. Coe BP, Girirajan S, Eichler EE. The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet 2012;160C:118-129.
27. Coe BP, Witherspoon K, Rosenfeld JA, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet 2014;46:1063-1071.
28. Béri-Dexheimer M, Latger-Cannard V, Philippe C, et al. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet 2008;16:1014-1018.
29. de Leeuw N, Bulk S, Green A, et al. UBE2A deficiency syndrome: Mild to severe intellectual disability accompanied by seizures, absent speech, urogenital, and skin anomalies in male patients. Am J Med Genet A 2010;152A:3084-3090.
30. Dsouza RS, Levandowski C, Slavov D, et al. Danon disease: clinical features, evaluation, and management. Circ Heart Fail 2014;7:843-849.
31. Czeschik JC, Bauer P, Buiting K, et al. X-linked intellectual disability type Nascimento is a clinically distinct, probably underdiagnosed entity. Orphanet J Rare Dis 2013;8:146.
32. Tarpey PS, Smith R, Pleasance E, et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 2009;41:535-543.
33. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013;42: 15-33.
34. Curnow KJ, Wilkins-Haug L, Ryan A, et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015;212:79.e1-79.e9.
35. Pinto D, Marshall C, Feuk L, Scherer SW. Copy-number variation in control population cohorts. Hum Mol Genet 2007;16 Spec No. 2:R168-R173.
36. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011;13:680-685.
37. Green RC, Berg JS, Grody WW, et al.; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-574.
38. Osato M, Yanagida M, Shigesada K, Ito Y. Point mutations of the RUNx1/AML1 gene in sporadic and familial myeloid leukemias. Int J Hematol 2001;74: 245-251.
39. Conrad DF, Keebler JE, DePristo MA, et al.; 1000 Genomes Project. Variation in genome-wide mutation rates within and between human families. Nat Genet 2011;43:712-714.
40. Vanakker O, Vilain C, Janssens K, et al. Implementation of genomic arrays in prenatal diagnosis: The Belgian approach to meet the challenges. Eur J Med Genet 2014;57:151-156.